BCLI Sankesh Abbhi bought BRAINSTORM CELL THERAPEUTICS INC. shares — SEC Form 4BUYBRAINSTORM CELL THERAPEUTICS INC.

Sankesh Abbhi, Director at BRAINSTORM CELL THERAPEUTICS INC. (BCLI), bought 46,779 shares at $12.99 ($608K) on 2020-07-15, disclosed to the SEC on 2020-07-16.

SEC EDGAR Filing

0001104659-20-084127

View on SEC EDGAR

Why this matters (generating…)

High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.

Modest57/100

Nothing distinguishes this filing.

First-Time BuyerOpportunistic Buy

Filing Info

Filed2020-07-16

Traded2020-07-15

Accession0001104659-20-084127

Sourcesec_form345

Insider

NameSankesh Abbhi

TitleDirector

PIT GradeInsiderUnrated

View Company View Insider

Get an email when an insider at BCLI files

Free account. Follow BCLI and up to 10 more companies.

Follow BCLI for free

BCLI Sankesh Abbhi bought BRAINSTORM CELL THERAPEUTICS INC. shares — SEC Form 4BUYBRAINSTORM CELL THERAPEUTICS INC.

Filing Info

Insider

Trade Details

Outcomes